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Individual Differences in Sensitivity to Nicotine: 
Implications for Genetic Research on Nicotine 
Dependence 
Ovide F. Pomerleau 1,2 
Recent evidence suggests that cigarette smoking has a heritability index around 53%. 
While related research on underlying mechanisms also supports the idea that genetic 
factors contribute to nicotine dependence--as well as to cofactors such as substance use 
and mood disorders--the nature of  the behavioral traits and biological capacity for re- 
inforcement that constitutes vulnerability to nicotine dependence is not well understood. 
The present review explores the problem of why some people become highly nicotine 
dependent, others develop a pattern of  occasional use, and still others avoid the drug 
entirely despite extensive exposure and widespread experimentation with tobacco in the 
population. Recent research--both infrahuman and human--suggests that vulnerability 
to nicotine dependence is related to high initial sensitivity to nicotine and that the de- 
velopment of  tolerance is more rapid and self-administration more extensive in such 
individuals. Relevant findings from neuroscience and biobehavioral research are reviewed 
in order to identify variables and methodologies that might improve the reliability and 
validity of  behavioral and molecular genetic studies on cigarette smoking. The integration 
of  research in these areas may lead to new insights in the understanding of nicotine 
dependence as well as to improved techniques for prevention and treatment. 
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I N T R O D U C T I O N  
Initiation into tobacco use was  once so c o m m o n  as 
to constitute a growing-up ritual, at least among  
male  adolescents.  In m a n y  parts o f  the world,  this 
is still the case. That  social factors in initiation are 
relevant  is indicated b y  the fact that the smoking  
status o f  friends is a good  predictor  o f  initiation o f  
smoking  (Bewley  et aL, 1974). Smoking  b y  parents 
and by  older siblings is also predictive,  however ,  
suggest ing the possible  contribution o f  genetic fac- 
tors as well. More  than 30 years  ago, Fisher (1958a, 
b) explored this possibil i ty and noted that concor-  
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dance for smoking  behavior  was higher in mono-  
zygotic  (MZ) twins than in dizygotic (DZ) twins. 
Some o f  the twins had not been  reared together,  
indicating that the similari ty be tween  the twins was  
not exclusively the result o f  environmental  influ- 
ence. These observat ions have been  replicated by  
numerous  investigators: Hughes ,  for example ,  iden- 
tified 18 twin studies in which  concordance rates 
for smokers  were  consistently greater  for  M Z  than 
for D Z  twins, with a mean  heritabili ty est imate o f  
53% for tobacco use, ranging f rom 28 to 84% 
(Hughes,  1986, Table  1). 
Other  twin studies have  demonst ra ted  that ge- 
netic factors not only  contribute to the initiation o f  
the smoking  habit  (Eaves and Eysenck,  1980; Han-  
nah et aL, 1984) but  also influence age o f  onset o f  
smoking  and number  o f  cigarettes smoked  per  day 
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(Heath and Martin, 1993) as well as persistence of  
smoking and intensity of  smoking--with signifi- 
cant genetic variation evident for both light and 
heavy smoking though not for moderate smoking 
(Carmelli et aL, 1992; Heath and Martin, 1993). 
Since alcohol use and caffeine consumption are 
also associated with smoking, Carmelli, Swan, and 
associates (Carmelli et al., 1990; Swan et aL, 1990) 
recalculated heritability estimates for smoking, tak- 
ing the correlation among these behaviors into ac- 
count: Before adjustment, genetic contribution for 
smoking, alcohol, and coffee use accounted for 53, 
36, and 45% of the variance, respectively, whereas 
after adjustment, the corresponding estimates were 
35, 29, and 36%--smaller but still significant. 
Recent research in molecular genetics sug- 
gests that there may also be commonalities at the 
level of  gene products and, mechanisms of  action 
for various addicting substances, among them nic- 
otine and alcohol (Collins 1990). Though the find- 
ings are still equivocal, a number of  studies have 
demonstrated increased prevalence of  the A1 and 
B1 alleles of  the dopamine receptor gene (DRD2) 
in smokers (Comings et al., 1993; Noble, 1993), in 
alcoholics (Noble, 1993; Uhl et aL, 1992), and in 
polysubstance users (Smith et aL, 1992). Not only 
have commonalities in the use of  tobacco, alcohol, 
and caffeine over the normal range of  consumption 
been identified using twin studies (Swan et aL, 
1994), but also significant genetic associations be- 
tween smoking and clinical depression (Kendler et 
al., 1993b) and alcohol use and clinical depression 
(Kendler et aL, 1993a) have been demonstrated, 
adding further support to the molecular studies. 
The above findings clearly indicate that ge- 
netic factors contribute to smoking (and to related 
substance use and mood disorders) in important 
ways. The nature of  the behavioral traits and bio- 
logical capacity for reinforcement that comprise 
vulnerability to nicotine dependence is not well un- 
derstood. It is evident, however, that some people 
seem destined to become smokers because of  
strong biological reasons for smoking, irrespective 
of  environmental factors: For instance, at the time 
of  the first exposure, they may be less reactive to 
nicotine's toxic effects and/or they may be more 
responsive to nicotine's reinforcing effects. On the 
other hand, from the onset, never-smokers may be 
more sensitive to nicotine's noxious effects or they 
may develop tolerance to nicotine's aversive ac- 
tions more slowly or they may simply fail to derive 
sufficient reinforcement from nicotine to sustain the 
habit. These possibilities have not been examined 
systematically, and the challenge for behavioral 
and molecular genetics will be to design studies 
that can take advantage of  the findings of  recent 
biobehavioral and neuroscience research. 
The present paper explores the problem of  
why--despite extensive exposure and widespread 
experimentation with tobacco---some people be- 
come highly nicotine dependent, others develop a 
pattern of  occasional use, and others avoid it en- 
tirely. A central premise is that, because initial re- 
inforcement consequences set the stage for subse- 
quent nicotine use, individual differences in 
sensitivity/reactivity to nicotine constitute a critical 
element in susceptibility. Following an introduction 
to basic terminology and a review of  current mod- 
els of  the relationship between sensitivity and de- 
pendence, the report focuses on a selective exam- 
ination of  recent research on individual differences 
on sensitivity to nicotine--both infrahuman and 
human-- in the process identifying pertinent varia- 
bles and methodologies. Subsequently, the 
implications for genetic research will be taken into 
account, by way of  encouraging a synthesis that 
might engender new insights in the understanding 
of  smoking. 
T E R M I N O L O G Y  AND BASIC CONCEPTS 
Terminology in the 1988 Surgeon General's 
Report, The Health Consequences o f  Smoking: Nic- 
otine Addiction (USDHHS, 1988, pp. 44-45, 289), 
is employed. Sensitivity indicates a situation in 
which, at initial exposure, there is greater response 
to a specified drug dose or in which a smaller drug 
dose suffices to elicit a specified level of  response. 
Tolerance is defined in two ways: (a) as decreased 
reactivity to a given dose of  the drug as a result of 
repeated administration over time and (b) as the 
need for a larger dose to maintain the effect orig- 
inally obtained. Tolerance is further differentiated 
into four subtypes: Dispositional (pharmacokinetic) 
tolerance refers to accelerated drug elimination 
(i.e., increased distribution and/or clearance) as a 
mechanism for explaining diminished effects after 
repeated dosing. Behavioral tolerance describes the 
decreased effect of  a given dose of  a drug as a 
result of  compensatory behaviors that reduce ad- 
verse effects on performance or activity. Condi- 
tioned tolerance refers to responses elicited by 
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association with drug administration--typically 
drug-opposite reactions that reduce drug effects. 
Funct ional  (pharmacodynamic) tolerance charac- 
terizes loss of  responsivity to dosing observed 
when dispositional and behavioral tolerance can be 
ruled out; more specifically, it refers to a condition 
in which drug concentration at the receptor si te--  
approximated in humans by plasma concentration 
of  the drug--produces a smaller effect as a result 
of  exposure. I f  functional tolerance develops within 
one or two exposures (i.e., during the period of  
drug agonist activity), it is referred to as tachyphy- 
laxis or acute tolerance. Tolerance that persists af- 
ter prolonged exposure is called acquired, or 
chronic tolerance. 
Drug  dependence is characterized as a process 
associated with regular exposure to a psychoactive 
substance in which neuroadaptations leading to a 
cycle of  escalating tolerance and increased self-ad- 
ministration occur until some asymptote is reached 
(Alexander and Hadaway, 1982). I f  the cycle is in- 
terrupted, by either withholding the drug or block- 
ing its action with an antagonist, the resulting dis- 
equilibrium is manifested by a withdrawal syn- 
drome, with characteristic signs and symptoms; 
readministration of  the drug provides relief unless 
its action is opposed by an antagonist. 
Tobacco smoking fits this general description 
of  addiction quite well: Nicotine is the major psy- 
choactive agent in tobacco, and after initiation, 
smoking behavior increases over a number of  
years, eventually reaching a point at which plasma 
nicotine levels stabilize and are maintained or 
"regulated" within characteristic limits (Koz- 
lowski, 1980; Russell, 1978). If  plasma concentra- 
tion falls below a certain level--different for each 
individual--smoking increases; if  nicotine exceeds 
a certain level, toxic symptoms appear and smoking 
(nicotine self-administration) is reduced. Once en- 
trained, these processes are highly resistant to 
change, for after a period of  abstinence from smok- 
ing, there is a strong desire to smoke ("craving")  
along with the aversive symptoms that characterize 
withdrawal (Killen et aL, 1988; Pomerleau et aL, 
1983). There is some disagreement about the exact 
percentage (Hughes et aL, 1987), but estimates sug- 
gest that from 50 to 80% of smokers can be clas- 
sified as nicotine dependent (American Psychiatric 
Association, 1994) by scoring positive on at least 
three of  the following in the same 12-month period 
(Greden and Pomerleau, in press): (1) tolerance, 
manifested by decreased effect of a given dose and/ 
or increased dosing to produce the same effect; (2) 
withdrawal after a period of  abstinence; (3) smok- 
ing a greater amount or over a more extended pe- 
riod than intended; (4) persistent desire to smoke 
and/or unsuccessful efforts to cut down; (5) 
considerable time spent obtaining or using tobacco; 
(6) important social, occupational, or recreational 
activities given up or curtailed because of  smoking; 
and (7) continued smoking despite knowledge of  
risks to health. 
T H E  E X P O S U R E  M O D E L  OF  T O L E R A N C E  
A N D  D E P E N D E N C E  
Only one-third to one-half of  those who ex- 
periment with tobacco go on to smoke regularly 
(McNeil, 1991). A commonly accepted explanation 
for why the remainder escape addiction is that these 
people have high innate sensitivity to nicotine and, 
as a result, encounter aversive effects on initial use, 
thus limiting further experimentation (Silverstein et 
al., 1982); with no further exposure to nicotine, ac- 
cording to this conceptualization, there is no op- 
portunity to develop tolerance. On the obverse side, 
people with less sensitivity to nicotine experience 
fewer unpleasant effects and are more likely to con- 
tinue smoking (Friedman et al., 1985). Because in- 
ception of  smoking is typically aversive (Bewley 
et aL, 1974), initial use is presumed to be main- 
tained by social reinforcement such as peer pres- 
sure (Friedman et al., 1985; Hirschman et al., 
1984; Presti et al., 1992). After a certain critical 
exposure, however, dependence develops and the 
habit is now maintained by the avoidance of  nic- 
otine withdrawal (McNeil, 1991). 
Furthermore, depending on environmental 
conditions, individuals become differentiated into 
heavy smokers or light smokers based on their ex- 
posure to nicotine; thus, heavy smokers are char- 
acterized as highly nicotine dependent because they 
typically have difficulty abstaining, are highly tol- 
erant to nicotine, and exhibit greater withdrawal 
upon discontinuation of  smoking than light smok- 
ers (Killen et al., 1988; Pomerleau et al., 1983). 
Since chronic tolerance is seen as a consequence 
of  the extent of nicotine exposure (Gurling et al., 
1985), this explanation of  individual variability in 
smoking patterns has been called the "exposure 
model"  (Pomerleau et al., 1993a). Whether an in- 
dividual smokes or not  is the result of  initial sen- 
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sitivity to nicotine, but degree o f  dependence is 
determined by exposure to nicotine under the influ- 
ence of  environmental variables such as social sup- 
port. A diagram of  the exposure model is provided 
in Fig. 1. 
Because o f  its plausibility and also because of  
the difficulty of  observing initiation of  smoking di- 
rectly, key elements of  the exposure model have 
yet to be validated. For example, the critical 
amount of  exposure to nicotine needed to differ- 
entiate tobacco users into light and heavy smokers 
and to establish degree of  dependence cannot be 
specified. Further, though the exposure model holds 
that people who are more sensitive to nicotine's 
aversive effects are less likely to become smokers, 
the empirical evidence for this assertion is weak, 
and the relationship between initial sensitivity to 
nicotine and tolerance is not as obvious as the 
model would imply. The assumption that "nicotine 
exposure is the engine that drives tolerance" (Pom- 
erleau et al., 1993a) has been questioned (see Shiff- 
man, 1991b). The two sections that follow review 
recent neuroscience and biobehavioral research 
findings with respect to individual variability in the 
initiation of  smoking and the development of  tol- 
erance and dependence. 
M o l e c u l a r  a n d  I n f r a h u m a n  Studies  
For over a decade, Collins and his associates 
have used inbred mouse strains to explore the re- 
lationship between individual differences in sensi- 
tivity to nicotine and the use of  tobacco. From a 
genetic perspective, each individual mouse can be 
seen as the equivalent o f  a human monozygotic 
twin. The focus o f  recent studies has been to de- 
termine whether genetic factors regulate first-dose 
sensitivity to nicotine and the subsequent devel- 
opment of  tolerance; a secondary objective has 
been to find out whether these effects were the re- 
sult of  changes in number or affinity of  brain nic- 
otine receptors (Collins and Marks, 1989). The 
research has taken advantage of  the fact that nic- 
otine affects a wide variety of  behavioral and phys- 
iological processes that are readily measurable, 
including learning, locomotor activity, body tem- 
perature, respiration rate, heart rate, acoustic startle 
response, seizures, and adrenal hormone release. 
In a recent analysis o f  nicotine sensitivity in 
19 inbred strains of  mice, Marks et al. (1989b) re- 
vealed extensive differences in initial sensitivity to 
nicotine on key parameters such as the EDs0 (the 
nicotine dose that elicits 50% of  maximum possible 
change in a given measure of  activity). Two fac- 
t o r s - b o d y  temperature/activity and sensitivity to 
nicotine-induced seizures--accounted for 69% of  
the variance, suggesting that a limited number of  
genes were operative in determining initial sensi- 
tivity to nicotine and that two specific gene pools 
might be responsible for the observed effects. 
In a related experiment, Marks et al. (1989a) 
measured the binding number (maximal number of  
receptors, B ~ )  and binding affinity (degree of  
bonding between drug and receptor, expressed as a 
disassociation constant, KD) for receptors in eight 
brain regions for the 19 strains that had exhibited 
wide differences in initial sensitivity to nicotine. 
The mouse brain contains at least two nicotine re- 
ceptor classes, one exhibiting a high affinity for 
[3H]nicotine and the other for eL-[125I]bungarotoxin 
[BTX] in radioligand binding assays (Marks and 
Collins, 1982). Binding affinity did not differ sys- 
tematically (for either nicotine or BTX receptors) 
in the eight brain regions among the 19 strains, but 
the strains did vary in receptor number, with sig- 
nificant differences in receptor number in midbrain, 
hindbrain, hippocampus, hypothalamus, and collic- 
ulus across strains. Mice with a greater number of  
nicotine-receptor binding sites were more sensitive 
to nicotine in that they required lower doses of  nic- 
otine to elicit a particular response; this was indi- 
cated by an inverse relationship (r = - . 62 )  
between initial sensitivity, using Y-maze rears/ 
crosses and body temperature as indicators, and 
nicotine receptor number in the different strains; 
there was also an inverse relationship (r = --.63) 
between seizures and BTX-receptor number. Dif- 
ferences in receptor number accounted for approx- 
imately 36% of  the variance in sensitivity to 
nicotine. 
The development o f  tolerance was studied in 
a similar manner. Because Collins and associates 
suspected that tolerance to nicotine might be linked 
to initial sensitivity, mouse strains known to differ 
widely in sensitivity to nicotine were selected and 
were infused chronic saline or nicotine over 10 
days in order to engender tolerance (Collins and 
Marks, 1989). Some strains developed tolerance at 
the lowest infusion doses, but others developed tol- 
erance only at the highest doses; the strains also 
differed in the maximal amount of  tolerance 
evinced. The critical finding was that there was a 
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Fig. 1. Diagram of the exposure model of tolerance (from Pomerleau et aL, 1993a). 
strong positive correlation (r = .86) between the 
initial sensitivity to nicotine and the minimal in- 
fusion dose required to elicit a shift in the dose- 
response curve (i.e., the lower the dose required to 
elicit a given effect, the lower the dose required to 
induce a given degree of  tolerance). The general 
conclusion was that the strains with grea t e r  initial 
sensitivity to nicotine were the ones that developed 
tolerance to nicotine more readily and to a greater 
extent. 
Tolerance to chronic administration of  nico- 
tine was dose dependent and corresponded to an 
increase  in nicotinic and BTX binding (Marks et  
al., 1986). In light of  the observation that greater 
receptor number indicated greater sensitivity to nic- 
otine in different mouse lines, the up-regulation of 
the nicotine receptor (Ochoa et  aL, 1990) was puz- 
zling. Collins and Marks (1991) attempted to ex- 
plain the association between the development of 
tolerance (decreased reactivity) and an increased 
receptor number as the result of  receptor desensi- 
tization brought about by chronic dosing. It is 
known that nicotine functions as a mixed agonist- 
antagonist, in that nicotinic receptors are desensi- 
tized as part of  the process of agonist binding 
following nicotine administration and that this ef- 
fect persists much longer for nicotine than is the 
case for acetylcholine, the endogenous ligand for 
the nicotine receptor. Sustained inactivation of  the 
receptor due to chronic nicotine infusion--the 
functional equivalent of  receptor blockade--likely 
increases receptor number due to stimulation of  
neuronal synthesis of new receptors. Thus, accord- 
ing to Collins and Marks, the phenomenon of  nic- 
otine tolerance might be explained as a process by 
which receptor desensitization (i.e., reduction in the 
number of  activatable receptors) outstrips compen- 
satory receptor synthesis. Various alternative ex- 
planations are being explored as well, including the 
possibility that some of  the induced nicotine recep- 
tors are dysfunctional. Moreover, the characteris- 
tics of  the receptor-binding assay used in the re- 
search by Collins and Marks (1989), are being 
assessed: The assay detects a single, high-affinity 
nicotine binding site, and molecular genetic studies 
have revealed the existence of  severa l  nicotine re- 
ceptor subtypes, differentially distributed in the rat 
brain (Goldman et  al., 1987). Should one of  these 
receptor subtypes be critical to the regulation of  
tolerance to nicotine, and should mouse strains dif- 
fer in either number or regional distribution of  
these receptor subtypes, this might provide a par- 
simonious explanation of  differential tolerance de- 
velopment. 
Receptor changes may be critical for under- 
standing the development of  tolerance in people as 
well. For example, the recent observation that nic- 
otine binding is greater in selected brain regions of  
smokers at autopsy, compared with nonsmokers 
(Benwell et  al., 1988), suggests that similar proc- 
esses are operative at the human level. The signif- 
icance of  the experiments with inbred mouse lines 
is that it provides a model for identifying the re- 
actions that set the stage for subsequent nicotine 
intake and susceptibility to dependence in the neo- 
phyte smoker. The adequacy of  the approach is 
suggested by preliminary data indicating that the 
strains that were m o s t  sensitive to nicotine ini- 
t i a l l y - a n d  that developed the mos t  to lerance  fol- 
lowing chronic exposure--were the ones that con- 
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sumed the m o s t  n i c o t i n e  in a drinking solution 
(Collins and Marks, 1991), suggesting that the mice 
differed with respect to some factor related to the 
reinforcing effects of  nicotine. Overall, these re- 
sults indicate that initial sensitivity to nicotine may 
presage not only the development of  tolerance but 
the extent of  subsequent self-administration--a key 
element in dependence. Further confirmation will 
be required, but the trends emerging from the in- 
bred mouse studies contradict the conventional wis- 
dom that degree of  tolerance and dependence are 
simply the result of  differential exposure to nico- 
tine; they suggest, instead, than preexposure differ- 
ences in sensitivity play a much more critical role 
in determining dependence that previously sus- 
pected, a theme that is developed further in the next 
section. 
H u m a n  Studies  
Some key tenets of  the conventional exposure 
model were summarized recently by Perkins e t  al. 
(1993, p. 375): "One view of  the onset of  regular 
smoking suggests that repeated exposure to nico- 
tine gradually leads to reduced magnitude of  its ef- 
fects, including subjective effects. This reduction 
in drug effects with increasing drug exposure is 
termed chronic tolerance. The onset of  chronic tol- 
erance to nicotine may subsequently lead to greater 
smoking in an effort by the smoker to continue to 
obtain the same magnitude of  reinforcing effects of  
nicotine." The adequacy of  this model for explain- 
ing smoking is brought into question, however, by 
numerous "anomalies."  For example, Russell 
(1989) observed, with respect to recruitment to 
smoking, that it is still unclear whether the disap- 
pearance of  nausea and other aversive effects fol- 
lowing a period of  experimentation with smoking 
can be attributed to the development of  chronic tol- 
erance. He noted that, in studies using animals, 
chronic tolerance to nicotine develops after a few 
days of  steady intravenous infusion. As Benowitz 
(1991) has shown, however, the pharmacokinetic 
profile of  nicotine administration is quite different 
in smokers, consisting of  a sharp rise in plasma 
nicotine concentration, with arterial levels peaking 
as high as 100 ng/ml (about three times the venous 
concentration) while the cigarette is being smoked, 
followed by a rapid decay (half-life, 2 to 3 tl); thus, 
smoking produces a peak/trough pattern of  chronic 
nicotine exposure---a pattern associated with potent 
physiological and behavioral effects (Balfour, 
1993). The only study Russell could find that di- 
rectly compared reactivity in abstinent chronic 
smokers and nonsmokers found no evidence for 
chronic tolerance, in that there were no differences 
between the two groups in sensitivity to the effects 
of  an intravenous nicotine probe with respect to 
heart rate, blood pressure, and electroencephalo- 
graphic changes (Murphree, 1979). Furthermore, 
earlier investigations by West and Russell (1985; 
1988) had also noted that more dependent smok- 
e rs - smokers  who experienced greater withdrawal 
during abstinence--were actually m o r e  sensitive to 
the first cigarette smoked after 24 h of  abstinence. 
The significance of  these observations is that they 
explicitly link tolerance and degree of  nicotine de- 
pendence in smokers to individual differences in 
sensitivity to nicotine that may have predated ex- 
posure, rather than to degree of  exposure after in- 
itiation into smoking. 
The recent development of  several noninva- 
sive methods for administering controlled doses of  
nicotine in a manner that mimics the sharp rise and 
fall of  plasma nicotine from cigarette smoking 
(Pomerleau et  al . ,  1989) has provided the oppor- 
tunity to explore the phenomenon of  sensitivity to 
nicotine much more systematically than previously 
feasible at the human level. Not only can the dose 
and pharmacokinetics of  the nicotine delivery sys- 
tem be manipulated more readily than for cigarette 
smoking, but the potentially confounding contri- 
butions of  the several thousand compounds in to- 
bacco smoke are eliminated. Further, the vehicle 
for nicotine administration is novel for both smok- 
ers and nonsmokers, thereby minimizing the con- 
tributions of  habituation (including behavioral and 
conditioned tolerance) to the dosing vehicle. These 
new methods may be of  great help in elucidating 
the genetically transmitted behavioral and physio- 
logical characteristics that contribute to suscepti- 
bility to nicotine dependence. 
Pomerleau e t  al. (1993b) conducted an initial 
exploration of  the effects of  nicotine on heart rate 
and blood pressure in 10 smokers and 10 lifetime 
nonsmokers (no sustained use of  tobacco at any 
time). The approach used a brief, intranasal dose 
of  nicotine (administration time, <10 s) as a probe 
for studying individual differences in sensitivity to 
nicotine. Nicotine delivery was via an airbrush used 
as aerosolizer, with dosage based on precise, elec- 
tromechanical control of  intranasal spray duration 
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Fig. 2. Mean plasma nicotine +_ SE over time following administration o f  a fixed dose o f  nicotine via intranasal aerosol. Left, 10 
smokers dosed with 1.50 mg nicotine; middle, 3 never-smokers dosed with 0.50 mg  nicotine; right, 7 never-smokers dosed with 
0.25 mg nicotine (from Pomerleau et al., 1993b). 
[see intranasal nicotine aerosol device (Pomerleau 
et al., 1992a)]. All smokers abstained from smok- 
ing for 1 h (constituting minimal deprivation) and 
received 1.5 mg of  nicotine. The first three never- 
smokers received 0.5 mg of  nicotine, and since all 
three experienced nausea, the remaining seven re- 
ceived 0.25 mg of  nicotine. As shown in Fig. 2, 
mean peak plasma nicotine increment for the 10 
smokers was 11.5 ng/ml. For the three never-smok- 
ers who received a 0.5 mg dose, the peak increment 
was 12 ng/ml; for the seven never-smokers who 
received a .25 mg dose, it was 7.5 ng/ml. These 
results indicate that, at least for punctate dosing, 
nicotine accumulation in plasma per unit dose ad- 
ministered varied considerably between the groups: 
the ratio (mean plus or minus the standard error of  
the mean) of  peak plasma nicotine level (ng/ml) to 
dose administered (mg) was 6.69 ___ 1.51 in smokers 
and 28.08 _+ 3.88 in never-smokers, a highly signif- 
icant difference. Disparity in plasma nicotine ac- 
cumulation between smokers and nonsmokers has 
also been observed by Srivastava et al. (1991), who 
noted that plasma nicotine concentrations in never- 
smokers were twice those of  smokers following ap- 
plication of  a 30-mg transdermal nicotine patch. 
(Patches were presumed to have identical bioavail- 
ability.) 
One interpretation of  these findings is that 
smokers exhibited smaller plasma nicotine accu- 
mulation (i.e., evinced greater pharmacokinetic tol- 
erance) than never-smokers due to greater volume 
of  initial distribution; another possibility, though, 
is that smokers might have diminished bioavaila- 
bility through some mechanism involving differ- 
ential vasoconstriction or diminished nicotine trans- 
fer across the nasal mucosae. While the finding of  
greater accumulation of  nicotine in plasma of  
never-smokers was certainly in keeping with the 
common observation that never-smokers experi- 
ence aversive effects such as nausea and dizziness 
at lower doses of  nicotine than smokers, a proper 
evaluation of  pharmacodynamic (functional) toler- 
a n c e - w h i c h  reflects the effects o f  nicotine at brain 
nicotinic receptors--necessitated taking into ac- 
count the differences in level of  nicotine. 
Figure 3 examines these differences by com- 
paring plasma nicotine increment (peak concentra- 
tion minus baseline concentration) with heart rate 
and blood pressure increments (peak response mi- 
nus baseline response) for both smokers and never- 
smokers. [The peak for nicotine concentration was 
compared with the peak value for the response of  
interest in the analyses in order to eliminate the 
temporal disassociation between effects of  nicotine 
at the receptor level--manifested by physiological 
responses proportionate to the arterial nicotine con- 
centration--and the change in nicotine concentra- 
tion in venous circulation, which lags several 
minutes behind fluctuations in arterial concentra- 
tion (Porchet et al., 1987)]. Peak physiological 
reactivity for each subject was divided by the sub- 
ject 's  peak nicotine increment (which, in venous 
blood, was reached 5 to 10 min later). Thus, dif- 
ferences in pharmacodynamic sensitivity between 
smokers and never-smokers were compared on the 
basis o f  their reactivity per unit plasma nicotine, 
thereby canceling out the contribution o f  pharma- 
cokinetic differences between the two groups. Fi- 
nally, in order to take into account customary 
nicotine intake and, by extension, nicotine depend- 
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Fig. 3. Peak plasma nicotine increment and peak physiological response per unit nicotine dose administered (mean • SE). 
ence (Pomerleau et al., 1983), smokers and never- 
smokers were classified by cotinine level [cotinine 
is a major metabolite of  nicotine with a half-life 
of  18-20 h (Benowitz, 1991)]; values were obtained 
from samples obtained prior to nicotine dosing. As 
shown in Fig. 4, smokers varied considerably from 
one another, with cotinines ranging from less than 
50 to nearly 400 ng/ml; never-smokers, on the 
other hand, grouped in a column directly above the 
0 mg/ml level. The ratio expressing physiological 
reactivity per unit plasma nicotine was negatively 
correlated with plasma cotinine level in smokers, 
reaching statistical significance for heart rate (r = 
--.69) and systolic blood pressure (r = - .82) ,  
though not for diastolic pressure (r = - .48).  The 
finding of  an inverse relationship between sensitiv- 
ity to nicotine and intensity of  prior exposure to 
nicotine was not unanticipated, as it was in keeping 
with various demonstrations of  acute tolerance after 
nicotine dosing in minimally deprived smokers 
(Hughes and Hatsukami, 1986; Perkins et aL, 1993; 
Pomerleau et aL, 1983). 
While the finding that heavy smokers were 
less reactive to nicotine (i.e., they exhibited greater 
functional tolerance) than light smokers was ex- 
pected, the observation that never-smokers as a 
whole were not much more reactive to nicotine 
than regular smokers was surprising--considering 
that the procedure was biased toward showing di- 
minished nicotine reactivity in smokers due to 
tachyphylaxis (Porchet et al., 1988) caused by the 
lingering effects of  nicotine from the cigarette 
smoked an hour earlier. To investigate further the 
possibility that tachyphylaxis might be masking un- 
derlying sensitivity in smokers--as had been sug- 
gested by West and Russell (1985, 1988)--a com- 
parison of  the effects of  a nicotine probe was 
undertaken in five male never-smokers (from the 
study described above) and an age-matched cohort 
of  six light and six heavy smokers who had been 
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Fig. 4. Mean physiological reactivity (peak increment) per unit plasma nicotine (peak increment) for 10 smokers and 10 never- 
smokers as a function of  plasma cotinine level (from Pomerleau et al., 1993b). 
deprived overnight instead of  being minimally de- 
prived; since dosing was adjusted to take into ac- 
count likely differences in pharmacokinetic toler- 
ance between the smokers and the nonsmokers, the 
resulting plasma nicotine increments were nearly 
the same for the two groups. The findings corrob- 
orated the hypothesis that underlying differences in 
sensitivity to nicotine might be obscured by tach- 
yphylaxis from recent smoking in undeprived 
smokers: After overnight deprivation (to allow suf- 
ficient time for the contribution of  nicotine-agonist 
activity to dissipate), the heaviest smokers were 
also the most  reactive to nicotine, the never-smok- 
ers were the least reactive, and light smokers fell 
between the other two groups (Pomerlean et al., 
1992b). 
These findings replicated and extended Rus- 
sell's (1989) informal observation that, compared 
with less dependent smokers, smokers who are 
more dependent (i.e., those who experience more 
severe withdrawal symptomatology) are more sen- 
sitive to the first cigarette of  the day after 24 h of  
abstinence. Further, an important feature of  the 
present approach, is that, by utilizing the complete 
pharmacokinetic response to nicotine dosing (i.e., 
by determining the point of  inflection for plasma 
nicotine concentration), it was possible to factor out 
the contribution of  pharmacokinetic tolerance from 
that of  pharmacodynamic tolerance in order to ar- 
rive at a more accurate estimate of  functional sen- 
sitivity to nicotine for each subject. 
The findings provide a plausible explanation 
for numerous other "anomalous"  findings in lit- 
erature. For example, Lombardo et al. (1988) had 
examined physiological reactivity in overnight-de- 
prived smokers and found that more dependent 
smokers [classified using the FagerstrSm Tolerance 
Questionnaire; FTQ (Fagerstr6m, 1978)] exhibited 
greater  reactivity after smoking a usual cigarette 
than less dependent smokers; while the authors sur- 
mised that the results raised questions about the 
validity of  the FTQ for measuring phys ica l  de- 
pendence, an alternative explanation is that dissi- 
pation of  acute tolerance after overnight depriva- 
tion may have unmasked underlying differences in 
sensitivity to nicotine that set the stage for depend- 
ence- in the first place. In a similar vein, Lee et al. 
(1987) examined the effects o f  a nicotine probe af- 
ter various lengths of  smoking deprivation and 
found that, after 7 days of  abstinence, smokers 
were even more physiologically reactive to nicotine 
than after overnight deprivation. 
Taken in conjunction with the animal research 
by Collins and his associates, the intranasal nico- 
tine studies in humans suggest that preexisting dif- 
ferences in sensitivity to nicotine, rather than 
exposure to nicotine over time, determine subse- 
quent nicotine use; that is, people who are "des- 
t ined" to become heavy smokers may simply be 
more sensitive to nicotine's effects from the onset. 
A further inference is that, what passed as chronic 
functional tolerance in heavy smokers (based on 
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earlier studies in which systematic measurements 
of  plasma nicotine were not available to establish 
the peak) might simply be a physiological mani- 
festation of  acquired pharmacokinetic (metabolic) 
tolerance; in this case, diminished physiological 
reactivity would also be manifested, but for the rea- 
son that plasma levels for a given dose of  nicotine 
were lowered by enhanced disposition or clearance 
of  nicotine--an effect likely to be more pro- 
nounced in heavy smokers. 
Recent observations in a category of  smokers 
who show little evidence of  nicotine dependence 
strengthen these suppositions. According to Shift- 
man and associates, about 5% of  smokers clearly 
fail to meet the criteria for nicotine dependence 
(Shiffman, 1991b). Shiffman called these smokers 
"chippers," defined as long-term light smokers 
who smoke no more than five cigarettes per day at 
least 4 days per week. In contrast to regular smok- 
ers, one-fourth of  chippers studied abstained from 
smoking as frequently as 1 day per month. When 
chippers did smoke, moreover, they often waited 
until later in the day, experiencing considerable 
deprivation without apparent discomfort or with- 
drawal; chippers inhaled and absorbed normal 
amounts of  nicotine from each cigarette, however, 
revealing no signs of  compensation for low fre- 
quency of  smoking by taking in more nicotine from 
individual cigarettes (Shiffman et al., 1990). Over- 
all, in contrast to regular smokers--and despite the 
fact that chippers had smoked nearly 50,000 ciga- 
rettes over an average of  20 years--chippers dis- 
played a casual "take-it-or-leave-it" attitude to- 
ward smoking (Shiffman, 1989). 
Of particular relevance to the present thesis, 
chippers were remarkably insensitive to nicotine-- 
exhibiting no greater reactivity to nicotine (no less 
tolerance) than a matched group of  regular smok- 
ers, even though the regular smokers had consumed 
in excess of  five times more cigarettes over their 
lifetime (Shiffman et  al., 1992). Furthermore, there 
were no significant differences in nicotine half-life 
in plasma between chippers and regular smokers, 
indicating that the pattern of  intermittent nicotine 
administration by chippers was not simply due to 
a greater accumulation of  nicotine resulting from 
diminished nicotine disposition or clearance. 
An analysis of  smoking history, though ret- 
rospective and less precise than laboratory inves- 
tigation, revealed that chippers' insensitivity to 
nicotine may have predated the first experience of 
smoking in that they reported fewer aversive ex- 
periences to the first exposure than regular smokers 
(Shiffman, 1989). Evidence suggesting that reac- 
tion to nicotine might have a genetic basis comes 
from studies of  smoking in the parents and siblings 
of  chippers (Gnys and Shiffman, 1991; Shiffman, 
1989): Immediate relatives of  chippers were just as 
likely to have smoked as relatives of  regular smok- 
ers, but relatives of  chippers were less nicotine de- 
pendent--they smoked less, were more likely to 
have been chippers themselves, and were more suc- 
cessful at quitting smoking, and some (e.g., sisters) 
reported fewer withdrawal symptoms on cessation. 
Finally, relatives of chippers indicated that the on- 
set of  smoking occurred later in the day compared 
with regular smokers (even controlling for amount 
smoked); this finding is especially revealing given 
that the latency between waking and the first cig- 
arette of the day is considered the best single in- 
dicator of  dependence (Fagerstrrm, 1978; Koz- 
lowski et  al., 1981). Thus, in the aggregate, 
Shiffman's findings suggest that the ability to 
smoke without developing dependence may run in 
families. 
THE SENSITIVITY MODEL 
As indicated above, data from some recent an- 
imal and human experiments reveal difficulties 
with the exposure model as originally formulated. 
The findings suggest that individual differences in 
initial sensitivity to nicotine must play a much 
greater role in determining tolerance and depend- 
ence than has been taken into account. Accord- 
ingly, an alternative conceptualization, the sensitiv- 
ity model, has been proposed (see review by 
Pomerleau et al., 1993a): Initial exposure to nico- 
tine in individuals who have high innate sensitivity 
is seen as producing not only aversive effects but 
also highly reinforcing consequences, including 
temporary improvements in performance or affect 
along with termination of  nicotine withdrawal 
(Pomerleau, 1981; Pomerleau and Pomerleau, 
1984). As illustrated in Fig. 5, in such people, nic- 
otine exposure quickly leads to the development of  
tolerance; smoking is rapidly entrained and is rel- 
atively independent of  environmental support be- 
yond availability of  product and convenience, and 
discontinuation of  smoking leads to loss of  toler- 
ance along with intense withdrawal symptoms. 
Once the habit is entrained, these people meet the 
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Fig.  5. Diagram o f  the sensitivity mode l  (from Pomerleau et aL, 1993a). 
requirements for classification as highly dependent. 
On the other hand, people who are less sensitive to 
nicotine initially may experience less intense ef- 
fects from nicotine, and their reactions to nicotine 
may be less susceptible to change in response to 
further exposure. Depending on prevailing environ- 
mental and social conditions, such people will re- 
main nonsmokers or, in more supportive circum- 
stances for smoking, will develop a pattern of  
minimal or intermittent nicotine administration that 
reflects the limited reinforcement they obtain from 
nicotine; these people meet the requirements for 
classification as minimally dependent. 
The sensitivity model holds that constitu- 
tional 3 factors, operative prior to nicotine exposure, 
determine smoking status by delimiting the extent 
of  dependence possible for the individual. The de- 
velopment of  acute functional tolerance to effects 
that are toxic or aversive--an adaptation that may 
be proportional to the magnitude of  initial sensitiv- 
i t y - m a y  constitute a dampening of  sensitivity 
brought about by the disruption of  homeostasis by 
nicotine. Smokers may be selected from a popula- 
tion of  people who are highly sensitive to nicotine; 
furthermore, it is entirely possible that the en- 
hancement of  functional tolerance to the aversive 
effects of  nicotine is not accompanied by an equiv- 
alent loss of  sensitivity to its pleasurable or other 
reinforcing effects (see Robinson, 1993). Never- 
smokers, on the other hand, may be selected from 
a population of  people who are relatively insensi- 
3 The word  "const i tu t ional"  is used  to take into account  the 
possibi l i ty that prenatal  exposure  to nicotine (Slotkin et aL, 
1987; Zbuzek  and Chin,  1994) might  affect  the subsequent  
deve lopment  o f  dependence--- thus ,  both  genetic influences 
and intrauterine environmental  exposure  may  contribute to 
sensitivity to nicotine. 
five to nicotine and, therefore, have limited capa- 
bility to develop tolerance; these individuals fail to 
seek further exposure to nicotine, not because they 
are deterred by its aversive or toxic effects, but 
simply because they are not responsive to its blan- 
dishments. Chippers are the exception who prove 
the rule--relatively insensitive individuals who, by 
virtue of  their lack of  Sensitivity, have no need to 
develop tolerance to dampen the perturbations 
caused by nicotine; as a result, they can take up 
smoking on an occasional basis and they do not 
become dependent. An important inference that can 
be taken from the human research summarized 
above is that, when individual differences are ex- 
t ens ive -as  they are among regular smokers, oc- 
casional smokers, and never-smokers--genetic var- 
iability is a likely explanation (Collins and Marks, 
1989). 
Genet ic  Studies  
As described in a recent overview by Mc- 
Clearn et  al. (1991), the study of  genetic influences 
on behavior relied upon two main approaches in 
the past. The first was predicated on the search for 
single genes with influence sufficiently great as to 
be detectable against almost any genetic or envi- 
ronmental background; unfortunately, research 
quickly revealed that there were also large environ- 
mental influences in the expression of  the behaviors 
involved in substance abuse. The second general 
approach was the application of  statistical models 
of  quantitative genetics to partition the variance of  
continuously distributed phenotypes into various 
fractions attributable to the actions of  several 
genes---each with individually small effects--and 
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the influence of  environment. A third, more recent, 
approach involves the use of  molecular genetics as 
a tool for studying genes with effects which, while 
not overwhelming, can, nonetheless, account for 
appreciable proportions of  the variance. Substance 
abuse may be especially well suited for the last 
approach, given recent observations on genetic 
control in the expression of  dopamine receptors and 
that activation of  mesolimbic and mesocortical do- 
pamine systems serves as a common pathway for 
a variety of  addictive substances (Uhl et al., 1992). 
In a provocative commentary on genetic re- 
search on substance abuse, Kozlowski and Mc- 
Clearn (1991) pointed out that, despite similar 
estimates of  heritability for tobacco smoking and 
alcohol abuse, research on the human genetics of  
smoking has not developed as extensively. For in- 
stance, other than a brief mention that genes may 
contribute to individual differences in vulnerability 
to tobacco use, there is little discussion of  genetic 
research in the Surgeon General's comprehensive 
review of  nicotine addiction (USDHHS, 1988). Ac- 
cording to Kozlowski and McClearn, a possible ex- 
planation is that Fisher's "constitutional hypothe- 
sis" (Fisher, 1959) may have discouraged genetic 
research on tobacco smoking due to "guilt  by as- 
sociation": Fisher had argued that some gene or 
genes might be linked to both cancer and to smok- 
ing and concluded that smoking did not cause can- 
cer but was " m e r e l y "  a correlate. While the po- 
tential use of  this argument to exonerate tobacco 
companies from responsibility for product liability 
was indeed unfortunate, overreaction to the hy- 
pothesis expressed in its extreme form may have 
retarded research on the genetics of  smoking and 
nicotine dependence. Kozlowski and McClearn's 
(1991, p. 3) conclusion bears repetition: " I t  is not 
a case of  'nature versus nurture' in explaining var- 
iance in complex phenotypes; it is a case of  nature 
and nurture, with the scientific question being the 
relative influence of  these two general domains of  
influence on the trait under examination." 
Global measures of  heritability for complex 
behaviors such as smoking do not specify the mech- 
anisms that may have contributed to observed con- 
cordance. A pair of  twins, for example, may be 
concordant for smoking for a host of  reasons. Ac- 
cording to Kozlowski (1991), if  genes contributed 
to making someone more sensitive to the acute 
toxic effects of  smoking, this might cause not 
smoking to be inherited; if  genes caused some in- 
dividuals to find nicotine's psychoactive effects re- 
inforcing, however, this might also promote con- 
cordance for smoking. "These disparate encourag- 
ing and discouraging forces could then produce a 
high heritability of  a global measure, without nec- 
essarily informing about the diverse, and possibly 
genetically-independent, functional systems con- 
tributing to the concordance" (p. 519). Thus, the 
problem of  what is inherited is of  crucial impor- 
tance: Knowledge about the genetic basis for ni- 
cotine's aversive and reinforcing effects is required 
for a satisfactory explanation of  nicotine depend- 
ence. The remainder of  the discussion seeks to 
identify a few approaches that seem promising. 
Implications of Neuroscience and 
Biobehavioral  Research Findings for Genetic 
Studies 
It was said about Barbara McClintock, who 
won a Nobel Prize for her research on the genetics 
of  the "jumping gene,"  that she had " a  feeling for 
the organism." A similar " f e e l "  for smoking by 
researchers on the genetics of  nicotine and smoking 
is advisable. Because nicotine alters the bioavaila- 
bility of  numerous behaviorally and physiologically 
active neuroregulators, including acetylcholine, nor- 
epinephrine, dopamine, serotonin, [3-endorphin, va- 
sopressin, adrenocortiocotropic hormone (ACTH), 
and cortisol (Pomerleau and Rosecrans, 1989), nic- 
otine can be " u s e d "  by smokers to produce a va- 
riety of  effects, including temporary improvement 
in performance or affect. A potentially large num- 
ber of  exteroceptive and interoceptive cues unre- 
lated to the nicotine-dependence cycle (i.e., 
smoking to terminate or to avoid withdrawal) can 
serve as discriminative stimuli for smoking; this 
may account for how the habit can become so thor- 
oughly "interwoven into the fabric of  daily l iving" 
(Pomerleau and Pomerleau, 1984). The rapid action 
of  nicotine--along with its diverse neuroregulatory 
effects--makes it ideally suited to serve as a 
"pharmacological coping response";  it is available 
on demand and has effects that rarely outlast the 
circumstances that prompted its use. Oscar Wilde 
aptly conveyed the user's perspective some time 
ago: "Smoking is the perfect type of  a perfect 
pleasure. It is exquisite, and leaves one unsatisfied. 
What more could one want?"  
Dopamine (DA) pathways have attracted con- 
siderable attention in substance abuse research of  
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late, in part because increased DA secretion seems 
to be a common factor in determining the addictive 
properties of  most substances of  abuse (Clarke, 
1990b; Wise and Bozarth, 1987). Various drugs of 
abuse, including the "classic"  psychomotor stim- 
ulants--cocaine and amphetamine--are potent 
stimulators of  mesolimbic DA pathways, with con- 
comitant enhancement of  locomotor activity; 
though less potent, nicotine has similar actions. The 
reinforcing properties of these drugs--including 
nicotine--are also mediated by mesolimbic path- 
ways (Balfour, 1993; Di Chiara and Imperato, 
1988), and repeated daily administration causes 
sensitization (increased reactivity, or reverse toler- 
ance) of behavioral activation (Clarke, 1990a; Kita 
et  al. ,  1992; Robinson, 1993). An important con- 
sequence of  sensitization of  mesolimbic DA neu- 
rotransmission--described at some length in a re- 
cent theoretical paper by Robinson and Berridge 
(1993)--is that it enhances "incentive salience," 
hyperresponsivity to drug-associated stimuli as 
well as to the drug itself. The development of  in- 
creased reactivity following exposure to a drug 
suggests a mechanism that might explain how peo- 
ple with high sensitivity to nicotine could develop 
dependence rapidly and extensively compared with 
people who are less sensitive (see Pomerleau et  al. ,  
1993a): Since the direction and rate of  change in 
reactivity manifested as tolerance vary consider- 
ably across different response systems (Benowitz 
e t  al. ,  1982; Hasenfratz et  al. ,  1990; Perkins et  al. ,  
1991; Russell, 1989; USDHHS, 1988, pp. 47-49), 
there is the distinct possibility that the smoker des- 
tined to be highly dependent is the one who be- 
comes sensitized (that is, develops bigger effects 
over time) to nicotine's reinforcing effects while 
becoming tolerant to nicotine's aversive effects. 
This hypothesis is testable and deserves consider- 
ation. 
How a cigarette is smoked also can make a 
difference: Peak plasma nicotine concentration is 
typically reached around the time the cigarette is 
finished, and nicotine levels return to baseline after 
an hour or so. Russell (1990) has speculated that 
there may be two principal types of smokers: The 
first type, called the "peak seeker," is character- 
ized as someone who seeks out rewarding or stim- 
ulating sensations--effects that are associated with 
activation of  nicotine receptors via a rapid rise in 
plasma nicotine (Balfour, 1993). The second type, 
called the "trough maintainer," includes most 
heavy smokers, people who allow only short inter- 
vals between cigarettes. Compared with peak seek- 
ers, the smoking pattem of  trough maintainers is 
not associated with marked peaks and troughs in 
nicotine concentration. Though trough maintainers 
may obtain less nicotine from each cigarette, 
plasma nicotine levels nonetheless continue to ac- 
cumulate throughout the day, reaching an asymp- 
tote in late afternoon or early evening. For trough 
maintainers, the trigger to smoke may be a fall in 
plasma nicotine levels (reflecting diminishing nic- 
otine concentrations in brain), constituting an in- 
teroceptive aversive stimulus that presages nicotine 
withdrawal and/or the loss of  calming or sedative 
effects from the previous dose of nicotine; for peak 
seekers, however, the trigger may be an exterocep- 
tive stimulus (e.g., an event that announces per- 
formance demand or dYsPhoric mood) that sets the 
occasion for pleasurable or favorable consequences 
from nicotine self-administration (see Pomerleau 
and Pomerleau, 1984). Chippers may be the ulti- 
mate example of  peak-seekers, as they smoke in- 
termittently and get positive effects without expe- 
riencing an aversive withdrawal cycle (see 
Shiffman e t  al. ,  1994). For most dependent smok- 
ers, though, one or the other pattern of  smoking 
may predominate at various times, depending on 
environmental circumstances: intermittent, small 
doses may be taken in a context in which the stim- 
ulant or activating effects of  nicotine are reinforc- 
ing; higher, more frequent dosing may occur in a 
context in which the calming or sedating effects of  
nicotine are reinforcing; these effects are superim- 
posed on nicotine withdrawal cycle--characteristic 
for each individual--involving self-administration 
to avoid or escape an aversive abstinence state 
(Pomerleau and Pomerleau, 1984, pp. 508-509). 
Behavioral and molecular genetics research, 
by incorporating relevant findings from neurosci- 
ence and biobehavioral research, has the potential 
for explaining--in a much more complete and sat- 
isfactory fashion than be fo re - the  manner in which 
drug, environment, and organism come together to 
create addiction. As mentioned above, twin studies 
have been conducted on the heritability of  smoking 
in an attempt to define the gene-environment in- 
terface. The matched twin-pair design, for example, 
is a highly efficient way to assess the contribution 
of  environment and heredity because it controls for 
genetic similarity while seeking to identify the 
sources (environmental, constitutional, etc.) for dis- 
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cordance; a special feature is that relatively few 
discordant MZ twin pairs are needed to identify 
environmental contributions. To date, however, 
twin studies have relied mostly on self-report rather 
than more objective determination of  the pheno- 
type---i.e., actual measurement of  the subjective, 
behavioral, physiological, neuroendocrine, and bio- 
chemical response to nicotine (or to a nicotine an- 
alogue). Further, to characterize the nature of  
susceptibility to nicotine adequately, future explo- 
rations should examine not only dependent smok- 
ers who exhibit different patterns of smoking (e.g., 
peak seekers versus trough maintainers), but non- 
dependent smokers, exsmokers, and never-smok- 
ers. By extension, investigations of  twin pairs 
exhibiting known cofactors for smoking such as de- 
pression (Kendler et  al.,  1993b) and other psychi- 
atric states (Glassman, 1993) should be useful in 
identifying response tendencies that serve to in- 
crease the probability or the intensity of  nicotine 
dependence. Cofactors may be a limiting condition 
for quitting smoking in an increasing proportion of  
people in countries where active public health cam- 
paigns against smoking are operat ive- the  people 
who are the first to give up smoking are, by defi- 
nition, the "easy  quitters" (Glassman, 1993). 
Research on the neural pathways involved in 
drug reinforcement, such as the dopamine reward 
system mentioned above, shows great potential for 
generating important clues about genotypic mark- 
ers that might underlie the behavioral expression of 
substance abuse (Uhl et  al.,  1992). In particular, 
critical differences in the structure or expression of  
relevant genes may account for a substantial pro- 
portion of  the variance in dependence or in degree 
of  addiction. Moreover, the possibility of  using do- 
pamine agonists or antagonists as probes for stud- 
ying reinforcement-relevant responses such as be- 
havioral activation in people who are at the 
extremes of  nicotine dependence should be consid- 
ered. Either of  these approaches--genotyping or 
drug probes--might lead to more accurate specifi- 
cation of  potential for tolerance and dependence at 
the individual level. Furthermore, these approaches 
could provide the basis for new technologies for 
assessing likelihood of  initiation of  smoking or 
even ability to quit smoking. The effectiveness of  
prevention programs might be improved signifi- 
cantly, since biobehavioral susceptibility to nico- 
tine dependence could be predicted and character- 
ized. Among the possibilities for intervention and 
management are modification of  response tenden- 
cies that enhance susceptibility in individuals who 
are vulnerable (e.g., remediation of  traits or cofac- 
tors by behavioral or pharmacologic intervention-- 
or even gene therapy to modify sensitivity to 
nicotine's reinforcing effects) as well as the crea- 
tion of  alternatives to or substitutes for some of  
nicotine's neurochemical effects. 
CONCLUSION 
It may be that the abuse liability of  a given 
drug is determined by the extent to which sensitiv- 
ity to that drug resides in the gene pool (Pomerlean 
et  al.,  1993a). The current paucity of  techniques to 
counter the contribution of  organismic variables in 
substance abusers may explain, in part, why pre- 
vention strategies that rely principally on attempts 
to change social support for drug taking (e.g., pub- 
lic education and "just  say no"  campaigns) have 
failed to eradicate drug abuse. If  the tenets of  the 
sensitivity model are correct, modification of social 
support and other environmental contingencies has 
an impact largely on individuals who are relatively 
drug insensitive and, therefore, principally at risk 
of becoming light or intermittent users; people who 
are highly reactive and presumably highly vulner- 
able to drug use, however, will require a different 
approach. Moreover, when societal strictures for 
drug use become more severe, a shift in the balance 
of  the nature/nurture equation is effected, because 
people for whom drug-taking is less reinforcing are 
selected out first; for those people who remain 
users after such interventions, therefore, environ- 
mental sanctions will have to be supplemented by 
special procedures to counter genetic predisposi- 
tion. 
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